{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:08:24Z","timestamp":1785146904032,"version":"3.55.0"},"reference-count":278,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a chronic and progressive age-related neurodegenerative disease affecting up to 3% of the global population over 65 years of age. Currently, the underlying physiological aetiology of PD is unknown. However, the diagnosed disorder shares many common non-motor symptoms associated with ageing-related neurodegenerative disease progression, such as neuroinflammation, microglial activation, neuronal mitochondrial impairment, and chronic autonomic nervous system dysfunction. Clinical PD has been linked to many interrelated biological and molecular processes, such as escalating proinflammatory immune responses, mitochondrial impairment, lower adenosine triphosphate (ATP) availability, increasing release of neurotoxic reactive oxygen species (ROS), impaired blood brain barrier integrity, chronic activation of microglia, and damage to dopaminergic neurons consistently associated with motor and cognitive decline. Prodromal PD has also been associated with orthostatic hypotension and many other age-related impairments, such as sleep disruption, impaired gut microbiome, and constipation. Thus, this review aimed to present evidence linking mitochondrial dysfunction, including elevated oxidative stress, ROS, and impaired cellular energy production, with the overactivation and escalation of a microglial-mediated proinflammatory immune response as naturally occurring and damaging interlinked bidirectional and self-perpetuating cycles that share common pathological processes in ageing and PD. We propose that both chronic inflammation, microglial activation, and neuronal mitochondrial impairment should be considered as concurrently influencing each other along a continuum rather than as separate and isolated linear metabolic events that affect specific aspects of neural processing and brain function.<\/jats:p>","DOI":"10.3390\/antiox12051117","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T06:32:58Z","timestamp":1684391578000},"page":"1117","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9619-3059","authenticated-orcid":false,"given":"Shane Michael","family":"Ravenhill","sequence":"first","affiliation":[{"name":"School of Psychology and Public Health, La Trobe University, Bundoora 3083, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-981X","authenticated-orcid":false,"given":"Andrew Howard","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Walter and Eliza Hall Institute of Medical Research, Melbourne 3052, Australia"},{"name":"Epworth Hospital, Richmond 3121, Australia"},{"name":"Department of Neurology, Royal Melbourne Hospital, Melbourne 3050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1315-7563","authenticated-orcid":false,"given":"Sheila Gillard","family":"Crewther","sequence":"additional","affiliation":[{"name":"School of Psychology and Public Health, La Trobe University, Bundoora 3083, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kim, S.D., Allen, N.E., Canning, C.G., and Fung, V.S.C. (2018). Parkinson Disease, Elsevier Health Sciences.","DOI":"10.1016\/B978-0-444-63916-5.00011-2"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson\u2019s disease: Their ability to reproduce the features of clinical disease and model gene-environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"Neurotoxicology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Boyko, A.A., Troyanova, N.I., Kovalenko, E.I., and Sapozhnikov, A.M. (2017). Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson\u2019s and Alzheimer\u2019s Diseases. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122633"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","article-title":"Glial phagocytic clearance in Parkinson\u2019s disease","volume":"14","author":"Tremblay","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Picca, A., Guerra, F., Calvani, R., Bucci, C., Lo Monaco, M.R., Bentivoglio, A.R., Landi, F., Bernabei, R., and Marzetti, E. (2019). Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson\u2019s Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102373"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Koziorowski, D., Figura, M., Milanowski, \u0141.M., Szlufik, S., Alster, P., Madetko, N., and Friedman, A. (2021). Mechanisms of Neurodegeneration in Various Forms of Parkinsonism, Similarities and Differences. Cells, 10.","DOI":"10.3390\/cells10030656"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1017\/S1355617716000503","article-title":"Biomarkers in Prodromal Parkinson Disease: A Qualitative Review","volume":"22","author":"Cooper","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S656","DOI":"10.1002\/mds.22672","article-title":"When does Parkinson\u2019s disease begin?","volume":"24","author":"Gaig","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes\u2014Key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1017\/S1355617709090614","article-title":"Cognitive decline in Parkinson\u2019s disease: A prospective longitudinal study","volume":"15","author":"Muslimovic","year":"2009","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"761044","DOI":"10.3389\/fnagi.2021.761044","article-title":"Characteristics of Autonomic Dysfunction in Parkinson\u2019s Disease: A Large Chinese Multicenter Cohort Study","volume":"13","author":"Zhou","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1212\/WNL.0000000000012228","article-title":"Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder","volume":"97","author":"Shin","year":"2021","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","article-title":"Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: A case-control study","volume":"16","author":"Stokholm","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/mds.26415","article-title":"New clinical trials for non-motor manifestations of Parkinson\u2019s disease","volume":"30","author":"Schrag","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: A case-control study","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fphys.2018.00471","article-title":"The Microbiome-Mitochondria Dance in Prodromal Parkinson\u2019s Disease","volume":"9","author":"Cardoso","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","article-title":"The Gut-Brain Axis: Two Ways Signaling in Parkinson\u2019s Disease","volume":"42","author":"Dogra","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1523\/JNEUROSCI.1922-21.2022","article-title":"Microglia Drive Pockets of Neuroinflammation in Middle Age","volume":"42","author":"Moca","year":"2022","journal-title":"J. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflammaging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_24","first-page":"7219732","article-title":"Impact of Aging in Microglia-Mediated D-Serine Balance in the CNS","volume":"2018","author":"Eugenin","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnagi.2019.00056","article-title":"A Review and Hypothesized Model of the Mechanisms That Underpin the Relationship between Inflammation and Cognition in the Elderly","volume":"11","author":"Tangestani","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14883","DOI":"10.1002\/jcp.28318","article-title":"Regulation of autophagy as a therapy for immunosenescence-driven cancer and neurodegenerative diseases: The role of exercise","volume":"234","author":"Batatinha","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/13803395.2015.1087465","article-title":"Mild cognitive impairment in Parkinson\u2019s disease: Diagnosis and progression to dementia","volume":"38","author":"Galtier","year":"2016","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/1533317516653823","article-title":"Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease","volume":"31","author":"Safarpour","year":"2016","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Urbani, A., and Babu, M. (2019). Mitochondria in Health and in Sickness, Springer. [1st ed.].","DOI":"10.1007\/978-981-13-8367-0"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/joim.13088","article-title":"Mitochondria in human disease","volume":"287","author":"Larsson","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bse0470115","article-title":"Roles of mitochondria in human disease","volume":"47","author":"Duchen","year":"2010","journal-title":"Essays Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1093\/hmg\/ddx217","article-title":"Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis","volume":"26","author":"Khacho","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100843","DOI":"10.1016\/j.mam.2019.100843","article-title":"Emerging roles of beta-cell mitochondria in type-2-diabetes","volume":"71","author":"Las","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41569-018-0074-0","article-title":"Targeting mitochondria for cardiovascular disorders: Therapeutic potential and obstacles","volume":"16","author":"Bonora","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_37","first-page":"579","article-title":"Mitochondrial complex I deficiency and cardiovascular diseases: Current evidence and future directions","volume":"97","author":"Forte","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e5048","DOI":"10.7717\/peerj.5048","article-title":"Pathway analysis identifies altered mitochondrial metabolism, neurotransmission, structural pathways and complement cascade in retina\/RPE\/choroid in chick model of form-deprivation myopia","volume":"6","author":"Giummarra","year":"2018","journal-title":"PeerJ"},{"key":"ref_39","first-page":"S3","article-title":"The Emerging Evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_40","unstructured":"Evans, A.H. (2020). Parkinson\u2019s during COVID-19: Managing Treatments and Stress during a Pandemic."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e13575","DOI":"10.1111\/acel.13575","article-title":"\u201cReframing\u201d dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2\/Wnt driver: Therapeutical implications","volume":"21","author":"Marchetti","year":"2022","journal-title":"Aging Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","article-title":"Exposure to pesticides or solvents and risk of Parkinson disease","volume":"80","author":"Pezzoli","year":"2013","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1289\/ehp.1002339","article-title":"Association of cumulative lead exposure with Parkinson\u2019s disease","volume":"118","author":"Weisskopf","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jns.2017.06.030","article-title":"Worldwide trends in the prevalence of dementia","volume":"379","author":"Cova","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Badanjak, K., Fixemer, S., Smajic, S., Skupin, A., and Grunewald, A. (2021). The Contribution of Microglia to Neuroinflammation in Parkinson\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094676"},{"key":"ref_46","unstructured":"Suescun, J., Chandra, S., and Schiess, M.C. (2019). Translational Inflammation, Academic Press."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14789450.2017.1291344","article-title":"Proteomic studies associated with Parkinson\u2019s disease","volume":"14","author":"Kasap","year":"2017","journal-title":"Expert Rev. Proteom."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","article-title":"The burden of Parkinson\u2019s disease: A worldwide perspective","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The Incidence of Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_50","first-page":"718527","article-title":"Understanding the Burden on Caregivers of People with Parkinson\u2019s: A Scoping Review of the Literature","volume":"2014","author":"Bhimani","year":"2014","journal-title":"Rehabil. Res. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson Pandemic\u2014A Call to Action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.282.23.2215","article-title":"Caregiving as a risk factor for mortality: The Caregiver Health Effects Study","volume":"282","author":"Schulz","year":"1999","journal-title":"JAMA"},{"key":"ref_55","first-page":"1343","article-title":"Parkinsonism as a Third Wave of the COVID-19 Pandemic?","volume":"10","author":"Beauchamp","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_56","first-page":"351","article-title":"The Impact of the COVID-19 Pandemic on Parkinson\u2019s Disease: Hidden Sorrows and Emerging Opportunities","volume":"10","author":"Helmich","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"117179","DOI":"10.1016\/j.jns.2020.117179","article-title":"Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community","volume":"419","author":"Wijeratne","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson\u2019s disease: Advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.27534","article-title":"Pathogenesis-targeted therapeutic strategies in Parkinson\u2019s disease","volume":"34","author":"Jankovic","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00415-018-8838-3","article-title":"Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson\u2019s disease","volume":"265","author":"Stojkovic","year":"2018","journal-title":"J. Neurol."},{"key":"ref_63","first-page":"2381","article-title":"Early-onset mild cognitive impairment in Parkinson\u2019s disease: Altered corticopetal cholinergic network","volume":"7","author":"Kim","year":"2017","journal-title":"Science"},{"key":"ref_64","unstructured":"Dorszewska, J. (2016). Cognitive Impairment in Parkinson\u2019s Disease: Historical Review, Past, and Present, IntechOpen."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does Parkinson disease pathology begin in the brain?","volume":"61","author":"Bohl","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2015.08.032","article-title":"Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson\u2019s disease","volume":"1625","author":"Yao","year":"2015","journal-title":"Brain Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","article-title":"Noradrenaline in Parkinson\u2019s disease: From disease progression to current therapeutics","volume":"14","author":"Fornai","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson\u2019s disease: The case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jnc.13447","article-title":"Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: Noradrenergic signaling system","volume":"139","author":"Feinstein","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","article-title":"A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"42","author":"Mani","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"105014","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson\u2019s disease: The therapeutic role of Nrf2 activators","volume":"145","author":"Saravanan","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_74","first-page":"151","article-title":"The possible involvement of mitochondrial dysfunctions in Lewy body dementia A systematic Review","volume":"30","author":"Spano","year":"2015","journal-title":"Funct. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell Biology and Pathophysiology of alpha-Synuclein","volume":"8","author":"Burre","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_77","unstructured":"Laurent, G.J., and Shapiro, S.D. (2006). Encyclopedia of Respiratory Medicine, Academic Press."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"ref_81","first-page":"945","article-title":"Impact of dopamine oxidation on dopaminergic neurodegeneration","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson\u2019s disease: A role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394625-6.00001-5","article-title":"The Mitochondrial Free Radical Theory of Aging","volume":"127","author":"Barja","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","article-title":"The Mitochondrial Basis of Aging","volume":"61","author":"Sun","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI64125","article-title":"The role of mitochondria in aging","volume":"123","author":"Bratic","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(98)00046-0","article-title":"An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration","volume":"29","author":"Cassarino","year":"1999","journal-title":"Brain Res. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1152\/ajpendo.00125.2015","article-title":"Mitochondrial respiratory capacity and coupling control decline with age in human skeletal muscle","volume":"309","author":"Porter","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/iub.1126","article-title":"Mitochondrial involvement in neurodegenerative diseases","volume":"65","author":"Zsurka","year":"2013","journal-title":"IUBMB Life"},{"key":"ref_91","first-page":"34","article-title":"Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson\u2019s disease","volume":"2","author":"Navarro","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Rango, M., and Bresolin, N. (2018). Brain Mitochondria, Aging, and Parkinson\u2019s Disease. Genes, 9.","DOI":"10.3390\/genes9050250"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pbi.2004.03.007","article-title":"Respiratory metabolism: Glycolysis, the TCA cycle and mitochondrial electron transport","volume":"7","author":"Fernie","year":"2004","journal-title":"Curr. Opin. Plant Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35072063","article-title":"The genetics and pathology of oxidative phosphorylation","volume":"2","author":"Smeitink","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.bbabio.2012.02.033","article-title":"Bioenergetic role of mitochondrial fusion and fission","volume":"1817","author":"Westermann","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jmb.2019.03.006","article-title":"Microglia-Specific Metabolic Changes in Neurodegeneration","volume":"431","author":"Aldana","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jnc.14667","article-title":"Inhibition of bioenergetics provides novel insights into recruitment of PINK 1-dependent neuronal mitophagy","volume":"149","author":"Shin","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1242\/jcs.099234","article-title":"Mitochondria and cell signalling","volume":"125","author":"Tait","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Austin, G.L., Young, L.E.A., Johnson, L.A., and Sun, R. (2018). Mitochondrial Metabolism in Major Neurological Diseases. Cells, 7.","DOI":"10.3390\/cells7120229"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","article-title":"Mitochondrial Dynamics and Metabolic Regulation","volume":"27","author":"Wai","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_101","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Salmina, A.B., Kharitonova, E.V., Gorina, Y.V., Teplyashina, E.A., Malinovskaya, N.A., Khilazheva, E.D., Mosyagina, A.I., Morgun, A.V., Shuvaev, A.N., and Salmin, V.V. (2021). Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094661"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/07315724.2019.1683379","article-title":"Alzheimer\u2019s Disease and Parkinson\u2019s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and Environmental Chemicals","volume":"39","author":"Agnihotri","year":"2019","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"134347","DOI":"10.1016\/j.neulet.2019.134347","article-title":"Mitochondrial dysfunctioning and neuroinflammation: Recent highlights on the possible mechanisms involved in Traumatic Brain Injury","volume":"710","author":"Kaira","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010716-104908","article-title":"Repairing Mitochondrial Dysfunction in Disease","volume":"58","author":"Sorrentino","year":"2018","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4581909","DOI":"10.1155\/2021\/4581909","article-title":"Neuroinflammatory Mechanisms of Mitochondrial Dysfunction and Neurodegeneration in Glaucoma","volume":"2021","author":"Duarte","year":"2021","journal-title":"J. Ophthalmol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fneur.2019.01032","article-title":"Clinical significance of baseline neutrophil to lymphocyte ratio in patients with ischemic stroke or haemarragic stroke\u2014An updated Meta-Analysis","volume":"10","author":"Song","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_109","first-page":"716871","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"2011","author":"Keane","year":"2011","journal-title":"Park. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"McGuire, P.J. (2019). Mitochondrial Dysfunction and the Aging Immune System. Biology, 8.","DOI":"10.3390\/biology8020026"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.metabol.2017.11.010","article-title":"The emerging role of immune dysfunction in mitochondrial diseases as a paradigm for understanding immunometabolism","volume":"81","author":"Kapnick","year":"2018","journal-title":"Metabolism"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fpsyt.2018.00739","article-title":"Mitochondria, Microglia, and the Immune System-How Are They Linked in Affective Disorders?","volume":"9","author":"Culmsee","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: A balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/joim.12055","article-title":"The role of mitochondrial DNA mutations and free radicals in disease and ageing","volume":"273","author":"Lagouge","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","article-title":"Mitochondrial formation of reactive oxygen species","volume":"552","author":"Turrens","year":"2003","journal-title":"J. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","article-title":"Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: Rational insights for the therapeutic approaches","volume":"59","author":"Ahmad","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson\u2019s disease","volume":"177","author":"Kumar","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj1800129","article-title":"NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation","volume":"180","author":"Takeshige","year":"1979","journal-title":"Biochem. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"132931","DOI":"10.1016\/j.neulet.2017.06.050","article-title":"Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?","volume":"710","author":"Witte","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-genet-110410-132529","article-title":"Fusion and fission: Interlinked processes critical for mitochondrial health","volume":"46","author":"Chan","year":"2012","journal-title":"Annu. Rev. Genet."},{"key":"ref_122","first-page":"615","article-title":"Mitochondria-mediated damage to dopaminergic neurons in Parkinson\u2019s disease (Review)","volume":"41","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Annesley, S.J., and Fisher, P.R. (2019). Mitochondria in Health and Disease. Cells, 8.","DOI":"10.3390\/cells8070680"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Picca, A., Calvani, R., Coelho-Junior, H.J., Landi, F., Bernabei, R., and Marzetti, E. (2020). Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. Antioxidants, 9.","DOI":"10.3390\/antiox9080647"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Protasoni, M., and Zeviani, M. (2021). Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020586"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnins.2019.00030","article-title":"Mitochondrial Dysfunction in Neural Injury","volume":"13","author":"Zhao","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jnc.12361","article-title":"Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells","volume":"127","author":"Park","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"824888","DOI":"10.3389\/fnins.2022.824888","article-title":"Microglia and Astrocyte Function and Communication: What Do We Know in Humans?","volume":"16","author":"Garland","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_129","unstructured":"Harry, G., and McPherson, C. (2014). Handbook of Neurotoxicity, CRC Press."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Aires, I.D., Ribeiro-Rodrigues, T., Boia, R., Ferreira-Rodrigues, M., Gir\u00e3o, H., Ambr\u00f3sio, A.F., and Santiago, A.R. (2021). Microglial extracellular vesicles as vehicles for neurodegeneration spreading. Biomolecules, 11.","DOI":"10.3390\/biom11060770"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/sni.sni_441_16","article-title":"Parkinson\u2019s disease: Microglial\/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration","volume":"8","author":"Blaylock","year":"2017","journal-title":"Surg. Neurol. Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonzalez","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases:an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/glia.23271","article-title":"Bioenergetic regulation of microglia","volume":"66","author":"Ghosh","year":"2018","journal-title":"Glia"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/biof.1597","article-title":"The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review","volume":"46","author":"Bagheri","year":"2019","journal-title":"Biofactors"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-4-47","article-title":"Does neuroinflammation fan the flame in neurodegenerative diseases?","volume":"4","author":"Alto","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","article-title":"TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease","volume":"302","author":"Ren","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"101202","DOI":"10.1016\/j.arr.2020.101202","article-title":"Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases","volume":"65","author":"Wu","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mds.27874","article-title":"Targeting the microglial NLRP3 inflammasome and its role in Parkinson\u2019s disease","volume":"35","author":"Haque","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.4103\/1673-5374.306060","article-title":"Chronic peripheral inflammation: A possible contributor to neurodegenerative diseases","volume":"16","author":"Lana","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"780811","DOI":"10.3389\/fnagi.2022.780811","article-title":"Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders","volume":"14","author":"Ponce","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.12659\/MSM.901995","article-title":"Resolvin D1 Attenuates Mpp+-Induced Parkinson Disease via Inhibiting Inflammation in PC12 Cells","volume":"23","author":"Xu","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1084\/jem.20120741","article-title":"Prion-like spread of protein aggregates in neurodegeneration","volume":"209","author":"Polymenidou","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Freeman, D., Cedillos, R., Choyke, S., Lukic, Z., McGuire, K., Marvin, S., Burrage, A.M., Sudholt, S., Rana, A., and O\u2019Connor, C. (2013). Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062143"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"\u03b1-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Liu","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"104961","DOI":"10.1016\/j.neubiorev.2022.104961","article-title":"Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments","volume":"144","author":"Rehman","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.1424741112","article-title":"Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance","volume":"112","author":"Carta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10072-019-04165-y","article-title":"Identification of distinct blood-based biomarkers in early stage of Parkinson\u2019s disease","volume":"41","author":"Wu","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13024-019-0335-3","article-title":"Microglia affect alpha-synuclein cell-to-cell transfer in a mouse model of Parkinson\u2019s disease","volume":"14","author":"George","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded aggregation and toxicity of {alpha}-synuclein and tau: Cellular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in Physiology and Disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41380-019-0609-8","article-title":"Microglial regional heterogeneity and its role in the brain","volume":"25","author":"Tan","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","article-title":"Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fncel.2013.00065","article-title":"Functional diversity of microglia\u2013how heterogeneous are they to begin with?","volume":"7","author":"Hanisch","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: Active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Simpson, D.S.A., and Oliver, P.L. (2020). ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease. Antioxid. Redox Signal., 9.","DOI":"10.3390\/antiox9080743"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bbi.2020.05.052","article-title":"Selective inhibition of mitochondrial respiratory complexes controls the transition of microglia into a neurotoxic phenotype in situ","volume":"88","author":"Chausse","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fncel.2014.00101","article-title":"Microglial diversity by responses and responders","volume":"8","author":"Gertig","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e1102","DOI":"10.1038\/cddis.2014.70","article-title":"Extracellular ATP drives systemic inflammation, tissue damage and mortality","volume":"5","author":"Cauwels","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the Immune System in Hypertension","volume":"97","author":"Pons","year":"2017","journal-title":"Physiol. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.mito.2018.09.003","article-title":"Microglia polarization by mitochondrial metabolism modulation: A therapeutic opportunity in neurodegenerative diseases","volume":"46","author":"Angelini","year":"2019","journal-title":"Mitochondrion"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","article-title":"Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases","volume":"87","author":"Smith","year":"2012","journal-title":"Brain Res. Bull."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease","volume":"58","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2741\/s433","article-title":"Ageing, neuroinflammation and neurodegeneration","volume":"7","author":"Ward","year":"2015","journal-title":"Front. Biosci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fncel.2017.00216","article-title":"Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration","volume":"11","author":"Kempuraj","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"ref_179","first-page":"713517","article-title":"Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease","volume":"2011","author":"Litteljohn","year":"2011","journal-title":"Park. Dis."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","article-title":"Cytokine expression and microglial activation in progressive supranuclear palsy","volume":"17","author":"Ahmed","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/01616412.2016.1249997","article-title":"Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Pal","year":"2016","journal-title":"Neurol. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","article-title":"Neuroinflammation\u2014A major cause for striatal dopaminergic degeneration in Parkinson\u2019s disease","volume":"381","author":"Kaur","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: The contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/07853890009011761","article-title":"Apolipoprotein E4: An allele associated with many diseases","volume":"32","author":"Smith","year":"2000","journal-title":"Ann. Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwj283","article-title":"Serum cholesterol levels and the risk of Parkinson\u2019s disease","volume":"164","author":"Koudstaal","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","article-title":"Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease","volume":"256","author":"Goris","year":"2009","journal-title":"J. Neurol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2106.e1","DOI":"10.1016\/j.neurobiolaging.2011.05.016","article-title":"Apolipoprotein E genotypes and the risk of Parkinson disease","volume":"32","author":"Gao","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim. Biophys. Acta (BBA) Lipids Lipid Metab."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41593-021-00855-z","article-title":"Killing ageing neurons, one cell at a time","volume":"24","author":"Wagner","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/CPJ.0000000000000702","article-title":"Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease","volume":"10","author":"Davis","year":"2020","journal-title":"Neurol. Clin. Pract."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","article-title":"Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease","volume":"24","author":"Zalocusky","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3233\/JAD-190074","article-title":"The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo","volume":"70","author":"Simonovitch","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebrian","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1126\/science.7624779","article-title":"Induction of MHC class I genes in neurons","volume":"269","author":"Neumann","year":"1995","journal-title":"Science"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41419-020-02776-4","article-title":"Altered mitochondrial dynamics and function in APOE4-expressing astrocytes","volume":"11","author":"Schmukler","year":"2020","journal-title":"Cell Death Disord."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","article-title":"APOE genotype and stress response-a mini review","volume":"15","author":"Dose","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","article-title":"Effect of ApoE isoforms on mitochondria in Alzheimer disease","volume":"94","author":"Yin","year":"2020","journal-title":"Neurology"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Azam, S., Haque, M.E., Kim, I.S., and Choi, D.K. (2021). Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression. Cells, 10.","DOI":"10.3390\/cells10010150"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e13022","DOI":"10.1111\/sji.13022","article-title":"The role of innate immunity and inflammation in Parkinson s disease","volume":"93","author":"Oberg","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.201601184","article-title":"Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain","volume":"31","author":"Currais","year":"2017","journal-title":"FASEB J."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.arr.2015.02.001","article-title":"Ageing and inflammation\u2014A central role for mitochondria in brain health and disease","volume":"21","author":"Currais","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-017-0733-2","article-title":"Neuroinflammation in Neurodegenerative Disorders-a Review","volume":"17","author":"Schain","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0005-2728(00)00177-8","article-title":"Mitochondrial bioenergetics in aging","volume":"1459","author":"Lenaz","year":"2000","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchemneu.2017.12.004","article-title":"Reinforcing mitochondrial functions in aging brain: An insight into Parkinson\u2019s disease therapeutics","volume":"95","author":"Chandra","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exger.2018.04.008","article-title":"Aging impairs mitochondrial respiratory capacity in classical monocytes","volume":"108","author":"Pence","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mito.2010.05.014","article-title":"Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?","volume":"10","author":"Witte","year":"2010","journal-title":"Mitochondrion"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"4050796","DOI":"10.1155\/2019\/4050796","article-title":"The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation","volume":"2019","author":"Bajwa","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00702-015-1399-z","article-title":"New insights on Parkinson\u2019s disease genes: The link between mitochondria impairment and neuroinflammation","volume":"122","author":"Trudler","year":"2015","journal-title":"J. Neural. Transm."},{"key":"ref_212","first-page":"9719","article-title":"Novel evidence for complement system activation in chick myopia and hyperopia models: A meta-analysis of transcriptome datasets","volume":"7","author":"Riddell","year":"2017","journal-title":"Science"},{"key":"ref_213","first-page":"872","article-title":"The retina\/RPE proteome in chick myopia and hyperopia models: Commonalities with inherited and age-related ocular pathologies","volume":"23","author":"Riddell","year":"2017","journal-title":"Mol. Vis."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"104484","DOI":"10.1016\/j.neuint.2019.104484","article-title":"A secret that underlies Parkinson\u2019s disease: The damaging cycle","volume":"129","author":"Sun","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech. Ageing Dev."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnins.2019.00303","article-title":"Chronic Microglial Activation in the GFAP-IL6 Mouse Contributes to Age-Dependent Cerebellar Volume Loss and Impairment in Motor Function","volume":"13","author":"Gyengesi","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Meszaros, A., Molnar, K., Nogradi, B., Hernadi, Z., Nyul-Toth, A., Wilhelm, I., and Krizbai, I.A. (2020). Neurovascular Inflammaging in Health and Disease. Cells, 9.","DOI":"10.3390\/cells9071614"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","article-title":"Aging and Parkinson\u2019s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis","volume":"115","author":"Calabrese","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Tronel, C., Largeau, B., Santiago Ribeiro, M.J., Guilloteau, D., Dupont, A.C., and Arlicot, N. (2017). Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040802"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Plaza-Zabala, A., Sierra-Torre, V., and Sierra, A. (2017). Autophagy and Microglia: Novel Partners in Neurodegeneration and Aging. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030598"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2013.04.013","article-title":"Microglia during development and aging","volume":"139","author":"Harry","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/JLB.3MR0118-003R","article-title":"Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain","volume":"103","author":"Santoro","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflammaging as two sides of the same coin: Friends or foes?","volume":"8","author":"Fulop","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1189\/jlb.1012544","article-title":"ROS production in phagocytes: Why, when, and where?","volume":"94","author":"Erard","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MED.0b013e32833c3026","article-title":"Mitochondrial dysfunction in obesity","volume":"17","author":"Bournat","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1172\/JCI116191","article-title":"Tissue distribution of beta 3-adrenergic receptor mRNA in man","volume":"91","author":"Krief","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fnagi.2017.00394","article-title":"Biological and Clinical Implications of Comorbidities in Parkinson\u2019s Disease","volume":"9","author":"Santiago","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nbd.2014.03.019","article-title":"System-based approaches to decode the molecular links in Parkinson\u2019s disease and diabetes","volume":"72 Pt A","author":"Santiago","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn.4631","article-title":"Microglia turnover with aging and in an Alzheimer\u2019s model via long-term in vivo single-cell imaging","volume":"20","author":"Fuger","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Presta, I., Vismara, M., Novellino, F., Donato, A., Zaffino, P., Scali, E., Pirrone, K.C., Spadea, M.F., Malara, N., and Donato, G. (2018). Innate Immunity Cells and the Neurovascular Unit. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123856"},{"key":"ref_232","first-page":"188","article-title":"New diagnostic pathways for mitochondrial disease","volume":"4","author":"Watson","year":"2020","journal-title":"J. Transl. Genet. Genom."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine","volume":"39","author":"Wallace","year":"2005","journal-title":"Annu. Rev. Genet."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","article-title":"Mitochondrial disease","volume":"368","author":"Schapira","year":"2006","journal-title":"Lancet"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.cdd.4402160","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"14","author":"Schapira","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref_238","first-page":"159160","article-title":"Mitochondrial contribution to Parkinson\u2019s disease pathogenesis","volume":"2011","author":"Schapira","year":"2011","journal-title":"Park. Dis."},{"key":"ref_239","first-page":"296","article-title":"The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. (Archives of Otolaryngology\u2014Head & Neck Surgery)","volume":"288","author":"Edmonds","year":"2002","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-804766-8.00014-5","article-title":"Parkinson\u2019s disease: Diagnosis and appreciation of comorbidities","volume":"167","author":"Deeb","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.parkreldis.2022.10.030","article-title":"Addressing critical care gaps in inpatient Parkinson\u2019s care\u2013Minimizing the impact of comorbidities and developing new care delivery models","volume":"104","author":"Yu","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41593-019-0486-0","article-title":"Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration","volume":"22","author":"Joshi","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_244","first-page":"479","article-title":"Parkinsonian Neurotoxins Impair the Pro-inflammatory Response of Glial Cells","volume":"11","author":"Serratosa","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Moya, G.E., Rivera, P.D., and Dittenhafer-Reed, K.E. (2021). Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137030"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.1998.275.2.E197","article-title":"Age-related increase in mitochondrial proton leak and decrease in ATP turnover reactions in mouse hepatocytes","volume":"275","author":"Harper","year":"1998","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.02.016","article-title":"Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress","volume":"1637","author":"Akbar","year":"2016","journal-title":"Brain Res."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.7150\/thno.29039","article-title":"Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia Using Dendrimer-Based Therapeutics","volume":"8","author":"Sharma","year":"2018","journal-title":"Theranostics"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Luna-S\u00e1nchez, M., Bianchi, P., and Quintana, A. (2021). Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168523"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1742-2094-7-45","article-title":"Effects of mitochondrial dysfunction on the immunological properties of microglia","volume":"7","author":"Ferger","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13238-015-0222-9","article-title":"Mitochondrial DNA in the regulation of innate immune responses","volume":"7","author":"Fang","year":"2016","journal-title":"Protein Cell"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1203\/01.pdr.0000233252.60457.cf","article-title":"Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency","volume":"60","author":"Reichenbach","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1242\/dmm.025684","article-title":"Immortalized Parkinson\u2019s disease lymphocytes have enhanced mitochondrial respiratory activity","volume":"9","author":"Annesley","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2016.04.012","article-title":"Mitochondrial control of cell bioenergetics in Parkinson\u2019s disease","volume":"100","author":"Bolanos","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnagi.2020.00100","article-title":"Mitochondrial Homeostasis and Signaling in Parkinson\u2019s Disease","volume":"12","author":"Scorziello","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Narendra, D.P., Jin, S., Tanaka, A., Suen, D., Gautier, C., Shen, J., Cookson, M.R., and Youle, R.J. (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000298"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","article-title":"Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies","volume":"218","author":"Elfawy","year":"2019","journal-title":"Life Sci."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/dneu.22748","article-title":"Developmental regulation of microtubule-based trafficking and anchoring of axonal mitochondria in health and diseases","volume":"81","author":"Cheng","year":"2021","journal-title":"Dev. Neurobiol."},{"key":"ref_261","first-page":"17590914211028364","article-title":"Mitochondrial and Organellar Crosstalk in Parkinson\u2019s Disease","volume":"13","author":"Ray","year":"2021","journal-title":"Am. Soc. Neurochem."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11064-021-03464-1","article-title":"Dopaminergic Axons: Key Recitalists in Parkinson\u2019s Disease","volume":"47","author":"Mishra","year":"2022","journal-title":"Neurochem Res."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Chen, C., Turnbull, D.M., and Reeve, A.K. (2019). Mitochondrial Dysfunction in Parkinson\u2019s Disease-Cause or Consequence?. Biology, 8.","DOI":"10.3390\/biology8020038"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jnc.12686","article-title":"Protective and toxic roles of dopamine in Parkinson\u2019s disease","volume":"129","author":"Paris","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13409","article-title":"Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice","volume":"136","author":"Villadiego","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"van Ham, T.J., Thijssen, K.L., Breitling, R., Hofstra, R.M., Plasterk, R.H., and Nollen, E.A.C. (2008). elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet., 4.","DOI":"10.1371\/journal.pgen.1000027"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","article-title":"Toxin models of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"16","author":"Martinez","year":"2012","journal-title":"Antioxid Redox Signal."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"117172","DOI":"10.1016\/j.jns.2020.117172","article-title":"Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study","volume":"419","author":"Kurihara","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_273","first-page":"150","article-title":"Cognitive Deficit and Aberrant Intrinsic Brain Functional Network in Early-Stage Drug-Naive Parkinson\u2019s Disease","volume":"16","author":"Zhang","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer\u2019s Disease","volume":"30","author":"Baik","year":"2019","journal-title":"Cell Metab."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbi.2017.10.017","article-title":"Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP\/PS1 mice","volume":"68","author":"Holland","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yexcr.2015.10.026","article-title":"Electron transport chain inhibitors induce microglia activation through enhancing mitochondrial reactive oxygen species production","volume":"340","author":"Ye","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/5\/1117\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:37:43Z","timestamp":1760125063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/5\/1117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":278,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["antiox12051117"],"URL":"https:\/\/doi.org\/10.3390\/antiox12051117","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}